Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Other financing activities (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Other financing activities for 3 consecutive years, with $84000.0 as the latest value for Q1 2026.

  • Quarterly Other financing activities rose 21.74% to $84000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $84000.0 through Jan 2026, down 97.45% year-over-year, with the annual reading at $3.2 million for FY2025, 37.02% up from the prior year.
  • Other financing activities for Q1 2026 was $84000.0 at Kestra Medical Technologies, up from -$69000.0 in the prior quarter.
  • The five-year high for Other financing activities was $3.2 million in Q3 2024, with the low at -$69000.0 in Q2 2025.
  • Average Other financing activities over 3 years is $661800.0, with a median of $69000.0 recorded in 2025.
  • The sharpest move saw Other financing activities tumbled 7000.0% in 2025, then increased 21.74% in 2026.
  • Over 3 years, Other financing activities stood at $3.2 million in 2024, then crashed by 102.14% to -$69000.0 in 2025, then surged by 221.74% to $84000.0 in 2026.
  • According to Business Quant data, Other financing activities over the past three periods came in at $84000.0, -$69000.0, and $69000.0 for Q1 2026, Q2 2025, and Q1 2025 respectively.